These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 26063364)
1. Gene Expression Profile of Persistent Postoperative Hypertension Patients with Aldosterone-producing Adenomas. Xie LF; Ouyang JZ; Wang AP; Wang WB; Li XT; Wang BJ; Mu YM Chin Med J (Engl); 2015 Jun; 128(12):1618-26. PubMed ID: 26063364 [TBL] [Abstract][Full Text] [Related]
2. Association of DNA polymorphisms within the CYP11B2/CYP11B1 locus and postoperative hypertension risk in the patients with aldosterone-producing adenomas. Wang B; Zhang G; Ouyang J; Deng X; Shi T; Ma X; Li H; Ju Z; Wang C; Wu Z; Liu S; Zhang X Urology; 2010 Oct; 76(4):1018.e1-7. PubMed ID: 20708777 [TBL] [Abstract][Full Text] [Related]
3. Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas. Mourad JJ; Girerd X; Milliez P; Lopez-Sublet M; Lejeune S; Safar ME Am J Hypertens; 2008 Jul; 21(7):742-7. PubMed ID: 18443567 [TBL] [Abstract][Full Text] [Related]
4. Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Rossi GP; Bolognesi M; Rizzoni D; Seccia TM; Piva A; Porteri E; Tiberio GA; Giulini SM; Agabiti-Rosei E; Pessina AC Hypertension; 2008 May; 51(5):1366-71. PubMed ID: 18347224 [TBL] [Abstract][Full Text] [Related]
5. Gene expression profiles in aldosterone-producing adenomas and adjacent adrenal glands. Wang T; Satoh F; Morimoto R; Nakamura Y; Sasano H; Auchus RJ; Edwards MA; Rainey WE Eur J Endocrinol; 2011 Apr; 164(4):613-9. PubMed ID: 21248073 [TBL] [Abstract][Full Text] [Related]
6. Polymorphic variation of CYP11B2 predicts postoperative resolution of hypertension in patients undergoing adrenalectomy for aldosterone-producing adenomas. Wang W; Hu WL; Zhang LC; Xiao YS; Liu J; Bin C Int J Urol; 2012 Sep; 19(9):813-20. PubMed ID: 22650983 [TBL] [Abstract][Full Text] [Related]
8. Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma. ; Wu VC; Chueh SC; Chang HW; Lin LY; Liu KL; Lin YH; Ho YL; Lin WC; Wang SM; Huang KH; Hung KY; Kao TW; Lin SL; Yen RF; Chen YM; Hsieh BS; Wu KD Am J Kidney Dis; 2009 Oct; 54(4):665-73. PubMed ID: 19628318 [TBL] [Abstract][Full Text] [Related]
9. Factors affecting complete hypertension cure after adrenalectomy for aldosterone-producing adenoma: outcomes in a large series. Zhang X; Zhu Z; Xu T; Shen Z Urol Int; 2013; 90(4):430-4. PubMed ID: 23466491 [TBL] [Abstract][Full Text] [Related]
10. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190 [TBL] [Abstract][Full Text] [Related]
11. Comparison of cardiovascular complications in patients with and without KCNJ5 gene mutations harboring aldosterone-producing adenomas. Kitamoto T; Suematsu S; Matsuzawa Y; Saito J; Omura M; Nishikawa T J Atheroscler Thromb; 2015; 22(2):191-200. PubMed ID: 25253161 [TBL] [Abstract][Full Text] [Related]
12. Primary aldosteronism: results of adrenalectomy for nonsingle adenoma. Quillo AR; Grant CS; Thompson GB; Farley DR; Richards ML; Young WF J Am Coll Surg; 2011 Jul; 213(1):106-12; discussion 112-3. PubMed ID: 21489832 [TBL] [Abstract][Full Text] [Related]
13. Small tumor size as favorable prognostic factor after adrenalectomy in Conn's adenoma. Giacchetti G; Ronconi V; Rilli S; Guerrieri M; Turchi F; Boscaro M Eur J Endocrinol; 2009 Apr; 160(4):639-46. PubMed ID: 19131503 [TBL] [Abstract][Full Text] [Related]
14. Bilateral aldosterone-producing adenomas: differentiation from bilateral adrenal hyperplasia. Wu VC; Chueh SC; Chang HW; Lin WC; Liu KL; Li HY; Lin YH; Wu KD; Hsieh BS QJM; 2008 Jan; 101(1):13-22. PubMed ID: 18203722 [TBL] [Abstract][Full Text] [Related]
15. Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. Letavernier E; Peyrard S; Amar L; Zinzindohoué F; Fiquet B; Plouin PF J Hypertens; 2008 Sep; 26(9):1816-23. PubMed ID: 18698217 [TBL] [Abstract][Full Text] [Related]
16. Inflammation and Fibrosis in Perirenal Adipose Tissue of Patients With Aldosterone-Producing Adenoma. Wu C; Zhang H; Zhang J; Xie C; Fan C; Zhang H; Wu P; Wei Q; Tan W; Xu L; Wang L; Xue Y; Guan M Endocrinology; 2018 Jan; 159(1):227-237. PubMed ID: 29059354 [TBL] [Abstract][Full Text] [Related]
17. Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma. Ishidoya S; Ito A; Sakai K; Satoh M; Chiba Y; Sato F; Arai Y J Urol; 2005 Jul; 174(1):40-3. PubMed ID: 15947573 [TBL] [Abstract][Full Text] [Related]
18. Incidence and factors of post-adrenalectomy hyperkalemia in patients with aldosterone producing adenoma. Chiang WF; Cheng CJ; Wu ST; Sun GH; Lin MY; Sung CC; Lin SH Clin Chim Acta; 2013 Sep; 424():114-8. PubMed ID: 23727469 [TBL] [Abstract][Full Text] [Related]
19. Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy. Fischer E; Hanslik G; Pallauf A; Degenhart C; Linsenmaier U; Beuschlein F; Bidlingmaier M; Mussack T; Ladurner R; Hallfeldt K; Quinkler M; Reincke M J Clin Endocrinol Metab; 2012 Nov; 97(11):3965-73. PubMed ID: 22893716 [TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with postoperative persistent hypertension in patients with primary aldosteronism. Obara T; Ito Y; Okamoto T; Kanaji Y; Yamashita T; Aiba M; Fujimoto Y Surgery; 1992 Dec; 112(6):987-93. PubMed ID: 1455323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]